$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
肝癌吃瑞格非尼生存期会延长吗?
2025-10-19 11:44:20
Check Details
靶向药卡博替尼(XL184)治疗肝细胞癌的效果怎么样?
2025-10-19 11:44:20
Check Details
肝癌骨转移病人可以用卡博替尼(XL184)治疗吗?
2025-10-19 11:44:20
Check Details
雷莫芦单抗治疗肝癌骨转移可行吗?
2025-10-19 11:44:20
Check Details
卡博替尼(XL184)在国家医保报销药品目录内吗?
2025-10-19 11:44:20
Check Details
肝癌服用瑞格非尼无效后怎么办?
2025-10-19 11:44:20
Check Details
肝癌晚期吃瑞格非尼管用吗?
2025-10-19 11:44:20
Check Details
【同比大幅下降】2021年仑伐替尼最新价格出炉
2025-10-19 11:44:20
Check Details
瑞戈非尼治疗肝癌的最佳剂量
2025-10-19 11:44:20
Check Details
2021年卡博替尼在国内纳入医保后的价格
2025-10-19 11:44:20
Check Details
卡博替尼可作为受过索拉非尼治疗过的肝细胞癌(HCC)患者的二线治疗
2025-10-19 11:44:20
Check Details
靶向药瑞戈非尼肝癌使用说明书
2025-10-19 11:44:20
Check Details
1
2
...
2869
2870
2871
2872
2873
2874
2875
...
4155
4156
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Cabozantinib: A Pan-Targeted TKI in Modern Oncology Practice
2
Managing Amivantamab Infusion Reactions: A Clinical Guide for International Practice
3
Onset Timeline and Efficacy Assessment of Margetuximab plus Chemotherapy in HER2-Positive Metastatic Breast Cancer
4
Avutometinib Plus Defactinib: A Precision Therapy for KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer
5
Vemurafenib (Zelboraf) Complete Medication Guide
6
Durvalumab Safety Profile: Managing Immune-Related Adverse Events (irAEs) in Clinical Practice
7
Zolbetuximab Combination Therapy: Global Efficacy and Safety Profile in CLDN18.2-Positive Advanced Gastric Cancer
8
Managing Mitotane Resistance in Adrenocortical Carcinoma: Strategies and Global Options
9
Trametinib & Dabrafenib in 2026: A Global Guide to Treating BRAF-Mutant Cancers
10
A Guide to Safely Stopping Mitotane: Why Tapering is Essential and How to Manage
11
Pemigatinib Efficacy: Significantly Improving Survival in FGFR2-Fusion Cholangiocarcinoma
12
Erlotinib: Targeting EGFR Mutations to Precisely Inhibit Non-Small Cell Lung Cancer Growth